H3K4 Methylation in Aging and Metabolism

epigenomes

Review H3K4 Methylation in Aging and Metabolism

Chia-Ling Hsu 1, Yi-Chen Lo 2 and Cheng-Fu Kao 1,*

1 Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 11529, Taiwan; [email protected] 2 Graduate Institute of Food Science and Technology, National Taiwan University, Taipei 10617, Taiwan; [email protected] * Correspondence: [email protected]

Abstract: During the process of aging, extensive epigenetic alterations are made in response to both exogenous and endogenous stimuli. Here, we summarize the current state of knowledge regarding one such alteration, H3K4 methylation (H3K4me), as it relates to aging in different species. We especially highlight emerging evidence that links this modification with metabolic pathways, which may provide a mechanistic link to explain its role in aging. H3K4me is a widely recognized marker of active transcription, and it appears to play an evolutionarily conserved role in determining organism longevity, though its influence is context specific and requires further clarification. Interestingly, the modulation of H3K4me dynamics may occur as a result of nutritional status, such as methionine restriction. Methionine status appears to influence H3K4me via changes in the level of S-adenosyl methionine (SAM, the universal methyl donor) or the regulation of H3K4-modifying enzyme activities. Since methionine restriction is widely known to extend lifespan, the mechanistic link between methionine metabolic flux, the sensing of methionine concentrations and H3K4me status may provide a cogent explanation for several seemingly disparate observations in aging organisms, including

age-dependent H3K4me dynamics, gene expression changes, and physiological aberrations. These connections are not yet entirely understood, especially at a molecular level, and will require further

Citation: Hsu, C.-L.; Lo, Y.-C.; Kao, elucidation. To conclude, we discuss some potential H3K4me-mediated molecular mechanisms that C.-F. H3K4 Methylation in Aging and may link metabolic status to the aging process. Metabolism. Epigenomes 2021, 5, 14. https://doi.org/10.3390/ Keywords: H3K4 methylation; aging; metabolism epigenomes5020014

Academic Editor: Ernesto Guccione 1. Introduction Received: 7 May 2021 Biological aging is characterized by the gradual accumulation of incidental damage at Accepted: 15 June 2021 the cellular, tissue, and organismal levels. This accumulated damage causes homeostatic Published: 18 June 2021 imbalances that may ultimately lead to a state of disease, such as cardiovascular and neu- rodegenerative diseases, metabolic disorders and cancer. There is no commonly accepted Publisher’s Note: MDPI stays neutral singular mechanism underlying the aging process, but a combination of factors including with regard to jurisdictional claims in genetics, environmental stimuli and metabolic changes have been shown to contribute published maps and institutional afﬁl- to the process [1–3]. Over the last few decades, the scope of interest in aging research iations. has broadened greatly, especially with regard to the molecular mechanisms underlying the aging process. Now, aging is typically thought of as a complex molecular program, largely because researchers have been able to increase/decrease lifespans of model organisms by numerous genetic and pharmacological means [4–9]. Nine tentative cellular Copyright: © 2021 by the authors. and molecular hallmarks of aging have been proposed to act together as determinants of Licensee MDPI, Basel, Switzerland. age-related phenotypes; these include genomic instability, telomere attrition, epigenetic This article is an open access article alterations, loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, distributed under the terms and cellular senescence, stem cell exhaustion, and altered intercellular communication [10]. In conditions of the Creative Commons particular, the study of epigenetic alterations in aging has recently attracted substantial Attribution (CC BY) license (https:// interest, owing to the fact that epigenetic markers can mediate the physiological effects creativecommons.org/licenses/by/ 4.0/). of environmental stimuli, such as dietary manipulations or stress, acting as a molecular

Epigenomes 2021, 5, 14. https://doi.org/10.3390/epigenomes5020014 https://www.mdpi.com/journal/epigenomes Epigenomes 2021, 5, 14 2 of 19

interface for gene–environment interactions throughout the lifespan of an organism [11]. Moreover, an ever increasing number of studies have established links between epigenetic changes and aging or age-related disorders and diseases [12,13]. During the process of aging, many types of epigenetic changes have been shown to occur in response to endogenous and exogenous stimuli. These changes include global changes in DNA methylation and histone modification patterns, the substitution of specialized histone variants for canonical histones, a global loss of core histones or the heterochro- matin architecture, and alterations in long non-coding RNA expression [14]. Together, such epigenetic mechanisms influence transcription and can contribute to the major alterations in gene patterns that have been consistently reported in aging cells [15–18]. Among the diverse modes of age-related genomic regulation, histone modifications are of interest for several reasons. First, multiple histone modifications with specialized epigenetic mechanisms, such as histone 3 lysine 4 tri-methylation (H3K4me3; activating mark) and H3K27me3 (repression mark), may help drive changes in gene expression that have been directly connected to lifespan in many organisms [2]. Second, several histone modifications, particularly methylation/acetylation-mediated histone modifications, are highly responsive to metabolic alterations. Changes in metabolism are the most common sign of aging within cells and thus may serve as an integration platform through which various metabolic signaling may converge to elicit specific age-related cellular responses [19,20]. Third, the potentially reversible nature of histone marks makes it conceivable that one could therapeutically revert the modifications to rescue age-related pathologies [21]. Lysine methylation of unstructured histone tails is an excellent example of a mechanism by which histone modifications intersect with nutrition and cellular metabolism to potentially influence gene expression and aging (or extend lifespan). Histone methylation is affected by metabolism through changes in the concentration of the metabolite, S-adenosylmethionine (SAM), which serves as the methyl donor for SAM-dependent methyltransferases to catalyze the methylation reaction. SAM is mainly derived from methionine, and the manipulation of the methionine levels has proven to be one of only a few dietary interventions that can robustly extend lifespan [22–24]. Furthermore, recent works show that the status of key histone marks, such as H3K4me3, can be dynamically tuned by the status of metabolic flux through methionine metabolism and the sensing of methionine bioavailability, which in turn alters gene expression [25,26]. Supporting this notion, other studies have confirmed that the changes in SAM levels or in the levels of certain metabolites that alter the activity of demethylases cause global changes in the patterns of histone methylations [27–33]. In parallel, numerous lines of evidence have linked changed levels of histone modifications to aging [34,35]. However, whether or not these histone marks can directly function as a metabolic sensor to couple cellular metabolic status with aging remains an open question, as the molecular mechanisms underlying how histone modification changes contribute to aging biology and longevity remain to be further explored. In this review, we focus on the specific epigenetic mark-H3K4 methylation (H3K4me), given its prominent association with gene transcription and its intricate connections with metabolism and aging-associated phenotypes. We first summarize current knowledge regarding the role of H3K4me in regulating aging in different species. Then, we present evidence linking this modification to metabolic pathways. Finally, we discuss potential molecular mechanisms by which H3K4me may function as an interface for extracellular signals to exert genomic effects that influence aging phenotypes.

2. H3K4 Methylation Marks Gene Expression across the Genome While lysine methylation on histones and its potential role in transcription was first described in the 1960s [36,37], it was about a decade later that specific lysine methylation sites on histones including H3K4me were identified in trout testes [38]. In subsequent studies, H3K4me was linked to gene activation in many eukaryotic organisms [39,40]. In general, H3K4me3 deposition peaks at the 50 end of transcribed genes, close to the transcription start site, and the peak is followed by a downstream gradient of H3K4 di-methylation Epigenomes 2021, 5, 14 3 of 19

(H3K4me2) and H3K4 mono-methylation (H3K4me1) deposits in the gene bodies of longer transcription units. In recent years, with advances of the ChIP-seq (chromatin immunopre- cipitation followed by sequencing) and MS (mass spectrophotometry)-related methods, the genome-wide distributions and abundances for all three states of H3K4me have been intensively assessed. In human cells, the global abundance of H3K4me3 comprises only about 1% of all H3K4me states. On the other hand, H3K4me2 and H3K4me1 are broadly distributed, with respective global abundances estimated at 1–4% and 5–20%, respectively [41]. H3K4me3 not only defines active transcription initiation sites at most promoters, but it is also functionally linked to other nuclear events and various cellular processes [42–47]. Sim- ilarly, H3K4me2 shows specific association with transcription factor binding regions [48] and tissue-specific intragenic cis-regulatory elements [49], while H3K4me1 is thought to mark enhancers [50,51]. However, studies in yeast and mammals show that loss of H3K4me only induces minor changes in gene expression [52–54], and some evidence has even suggested that H3K4me may passively accumulate on genes as a result of transcription, rather than exerting active functions [55]. Therefore, whether and how H3K4me contributes to the regulation of gene expression remains to be further clarified. Interestingly, recent studies in mammals suggest that atypical broad H3K4me3 domains are important for transcriptional precision at key cell identity/function genes [56] and for cell-type-specific gene expression [57,58]. The involvement of H3K4me3 in regulating gene expression across the lifetime of a cell has also been investigated recently in budding yeast (Saccharomyces cerevisiae) and worms (Caenorhabditis elegans)[59,60]. The studies in yeast have revealed impairments in the upregulation of aging-linked genes in H3K4me3-defective cells, coincident with reduced lifespan. In yeast cells, H3K4me3 normally has both repressive and inducing activities with regard to gene expression [40,52,61], but the inducing activity appears to be more important for a large subset of genes to attain normal expression levels, and the repressive capacity of H3K4me appears to decline as cells age. These studies provided an important demonstration that H3K4me3 is an active epigenetic mark that facilitates gene expression, and this mark is critical for maintaining cell viability throughout the lifespan of yeast [59]. Similarly, H3K4me3 in the somatic cells of C. elegans was reported to affect the expression of a set of genes with functions that are commonly implicated in aging biology. The genes marked by H3K4me at adult stages show age-dependent, correlated changes in H3K4me3 patterns and RNA expression [60]. Thus, further mechanistic investigations will be required to better understand how age-dependent changes in H3K4me3 help to regulate chromatin states and transcription during aging in these and other organisms.

3. H3K4 Methylation Is Involved in Biological Functions Other than Transcription Based on the studies mentioned above, H3K4me is thought to largely promote gene transcription. However, there is an increasing body of evidence showing that H3K4me is also involved in various other biological functions (Figure1). For example, a positive role of H3K4me in regulating origin firing has been suggested, as it is enriched near human early-firing origins relative to late-firing origins [62–64]. Origin firing is the initiation of DNA replication, and it takes place at well-defined replication origins in budding yeast [65]. In metazoans, origin firing occurs at specialized start sites thought to be determined by a combination of DNA sequence and chromatin-associated factors [66]. At these sites, DNA is first unwound by loading of pre-replicative complexes (pre-RCs) [67]. Then, replisomes are assembled and activated under the regulation of two kinases, S-CDK (S-phase cyclin- dependent kinase; Cdc28 complexed with either Clb5 or Clb6) and DDK (Dbf4-dependent kinase; Cdc7 complexed with Dbf4) [68]. It is known that not all replication origins are fired at the same time. While the molecular mechanisms underlying the preferential distribution of CDK and DDK to specific origins are not well understood, the kinetochore protein, Ctf19, and the forkhead proteins, Fkh1 and Fkh2, are thought to be involved [69–71]. Nevertheless, the DNA sequence and chromatin context at an origin appear to have the greatest influence on its likelihood of undergoing initiation [72–74]. Epigenomes 2021, 5, 14 4 of 19 Epigenomes 2021, 5, x FOR PEER REVIEW 5 of 20

FigureFigure 1. 1. H3K4H3K4 methylation methylation is is associated associated with with various biological functions. H3K4meH3K4me isis involvedinvolved in in a avariety variety of of mechanisms mechanisms affecting affecting nuclear nuclear functions. function Thes. The epigenetic epigenetic mark mark is thought is thought to promote to promote gene genetranscription, transcription, and thereand there is an increasingis an increasing body ofbody evidence of evidence showing showing that H3K4me that H3K4me is also involvedis also inin volvedvarious in other various nuclear other functions, nuclear functions, such as origin such firing,as origin replication firing, replication stress, and stress, DNA and damage DNA responses. damage responses. In addition to the role of H3K4me in human cells noted above, genome-wide profiling 4.of Writing H3K4me3 and in Erasing synchronized H3K4 Methylation yeast cells revealed that the mark is more readily erased duringThe S-phasestate of H3K4me at early origins (mono-(me1), than late di-(me2), origins or [75 tri-methylation]. The enrichment (me3)) of is H3K4me3 reversibly at early-firing origins (among a subset of defined origins) has also been demonstrated in regulated by the actions of histone lysine methyltransferases (KMTs; “writers”) and lysine synchronized human and monkey cells [76]. Remarkably, Rizzardi et al. provided genetic demethylases (KDMs; “erasers”) (Figure 2). It is clear that H3K4me is a highly dynamic evidence that H3K4me has functional consequences on origin activities. As such, they process, with the loss of basal activity of KMTs or KDMs, respectively, causing genome- found that two enzymes required for the methylation of H3K4 are necessary for robust wide decreases or increases in H3K4me levels. The structures and activities of KMTs and growth of several hypomorphic replication mutants [47]. Similarly, the loss of mammalian KDMs have been extensively reviewed elsewhere [79–81]; however, some relevant details H3K4 histone demethylase was shown to exert adverse effects on the initiation of early will be mentioned here. origins, suggesting the direct involvement of H3K4me in this process [77]. Thus, cur- H3K4 methylation is catalyzed by a series of KMTs, using SAM as a methyl group rent knowledge supports the idea that the methylation status of H3K4 is regulated by a donor. In S. cerevisiae (yeast), Set1 is the sole H3K4 KMT. The yeast complex associated concerted mechanism and affects origin activity. with Set1 (COMPASS) consists of a catalytic subunit Set1 and the concerted action of seven Some other observations further imply that H3K4me may be crucial to protect cells regulatory subunits (Swd1, Swd2, Swd3, Bre2, Sdc1, Spp1 and Shg1), which are responsi- from replication perturbations. For example, H3K4me protects stalled replication forks blefrom for deleteriousgenerating H3K4me1, degradation, H3K4me2, thus playing and H3K4me3 a role in maintaining[79]. Drosophila genome melanogaster stability (fruit [78]. fly)Moreover, carries three H3K4me Set1 homologs, functions downstreamdSet1, Trithorax of yeast(Trx), Rad53and Trithorax-related in the S-phase (Trr); checkpoint dSet1 isto responsible prevent transcription–replication for depositing the bulk of conflicts H3K4me2 (TRCs), and H3K4me3 which represent [82,83]. aIn major humans, source there of aregenome six Set1-related instability [proteins45]. Interestingly, that form H3K4me MLL/COMPASS also appears complexes, to be important including for two the efficienthomo- logsrepair of ofSet1—hSET1A DNA double-strand and hSET1B—and breaks, as the lossthe ofmixed-lineage H3K4me impairs leukemia the non-homologous (MLL) family (MLL1,end joining 2, 3 and pathway 4). MLL1 and and slows MLL2 progression are homologs through of D. S-phase melanogaster in the presenceTrx, while of MLL3 replication and MLL4stress are [44 ].homologs Together, of these D. melanogaster results indicate Trr [79]. that H3K4meAll of the is MLL/COMPASS important for faithful complexes DNA sharereplication a four undersubunit both subcompl normalex growth consisting conditions of Wdr5, and Rbbp5, replication Ash2 stress. and Dpy30, which are respectiveIn addition homologs to gene of yeast regulation Swd3, and Swd1, replication, Bre2 and H3K4me Sdc1, and also are regulates together other known cellular as WRADprocesses, [79,84]. such The as mitosisWRAD andsubcomplex apoptosis. must H3K4me associate was with shown different to play KMTs a role to inform regulat- var- iousing catalytic the response complexes, to benomyl, and its a presence microtubule-destabilizing is essential for full agent.enzymatic Notably, activity two [85,86]. different In C.mechanistic elegans, the explanations MLL/COMPASS for the complex benomyl-resistant contains a WRAD phenotype subcomplex of H3K4me-deficient associated with cells onewere of providedtwo KMTs, in either two separate the Set1-like papers. SET-2 Schibler or the et MLL-like al. described SET-16 an [85,87,88]. intriguing Of molecu- note, eachlar mechanism complex is whereinendowed H3K4me3 with additional regulates proteins the spindle that determine assembly checkpointH3K4me status (SAC) and by biologicaldirectly binding functions. to theIn ye activatedast COMPASS, form of Mad2,the WD40 a key protein component Swd2, ofPHD SAC, finger thus limitingprotein Spp1,its availability and Shg1 may [42]. be Interestingly, present [79]. anIn mamma alternativelian mechanismcells, unique wassubunits, proposed such byas WDR82 another (WDstudy. repeat The authorsdomain of82) that in the study hSET1A found complex, that Set1-H3K4 menin methylationin MLL1/2, and is required PTIP (Pax for propertrans- activationcell-cycle-dependent domain-interacting gene expression. protein) in A ML lackL3/4, of have Set1 delaysroles in entry regulating into S-phase, H3K4me which and recruitingsomehow distinct also impacts transcription the metaphase–anaphase factors for the expression transition. of specific Thus, target they genes proposed [89–91]. that H3K4Histone methylation methylation regulates was the originally cross-talk thought between to G1-Sbe stable transition and irreversible and mitosis [92]. [43]. How- While ever,more in work 2004, will the be discovery required of to unravelthe first thisH3K4 apparent KDM, discrepancy,human lysine the-specific studies demethylase agree on the

Epigenomes 2021, 5, x FOR PEER REVIEW 6 of 20

1A (KDM1A; also known as LSD1), revealed that H3K4me2 and H3K4me1 can both be removed by KDM1A/LSD1 through an FAD (flavin adenine dinucleotide)-dependent oxidation reaction; thus, histone methylation was shown to be reversible and dynamically Epigenomes 2021, 5, 14 regulated [93]. After that pioneering study, JARID1 (jumonji AT-rich interactive domain-5 of 19 1) family proteins (JARID1A/KDM5A, JARID1B/KDM5B, JARID1C/KDM5C and JARID1D/KDM5D) and the JmjC domain-containing protein (nucleolar protein 66 basic(NO66); principle also known that H3K4me as MAPJD) is important were found in coordinating to serve as cellH3K4 cycle demethylases progression in and human the propercells [94,95]. assembly It is of noteworthy the mitotic spindlethat unlike during KDM1A/LSD1, mitosis [42,43 which]. On catalyzes the other hand,demethylation the loss ofspecifically H3K4me hason H3K4me1/me2, been identiﬁed the asa KDM5A-D novel trigger proteins for apoptosis can function in yeast; as demethylases this study will for beall further three states discussed of H3K4me in a later [94,96]. section [46]. Despite our lack of understanding about the nuancedMuch role of of the H3K4me evidence in different supporting cellular the contexts,idea that mountingH3K4me evidencemay play overwhelmingly a crucial role in supportsaging comes the ideafrom that studies H3K4me in which plays the a levels multifunctional of KMTs and and KDMs context-dependent were modulated role in in C. manyelegans essential. In the C. cellular elegans processes. genome, there are three KDM1 genes (amx-1, spr-5, and lsd-1) and one KDM5 gene (rbr-2). The amx-1 gene encodes the sole KDM1B enzyme, while the other 4.two Writing KDM1 and genes Erasing are KDM1A H3K4 Methylation homologs. The sole KDM5 member, RBR-2, can act as a demethylaseThe state for of H3K4meH3K4me3 (mono-(me1), and H3K4me2, di-(me2), but it is or more tri-methylation efficient at (me3))removing is reversibly H3K4me3 regulated[97]. In contrast, by the actions the KDM1 of histone members lysine (SPR-5, methyltransferases LSD-1, and AMX-1) (KMTs; are “writers”) responsible and lysinefor re- demethylasesmoving H3K4me1 (KDMs; and “erasers”) H3K4me2 (Figure [98–102].2). It Interestingly, is clear that H3K4me targeting is adifferent highly dynamicclasses of process,KDMs (KDM1 with the versus loss ofKDM5) basal may activity differentially of KMTs or affect KDMs, the aging respectively, process causing[103,104]. genome- Despite widethis context decreases specificity, or increases it isin clear H3K4me that KDM-modulated levels. The structures H3K4 and demethylation activities of KMTsis function- and KDMsally relevant have been during extensively aging, and reviewed follow-up elsewhere studies [79 to– 81delineate]; however, the somemechanisms relevant will details help willreconcile be mentioned any apparent here. discrepancies [105–107].

FigureFigure 2. 2.List List of of histone histone lysine lysine methyltransferases methyltransferases (KMTs) (KMTs) and and demethylases demethylases (KDMs) (KDMs) responsible responsible forfor H3K4 H3K4 methylation methylation in in various various species. species. Blue Blue lines lines indicate indicate the the phylogenetic phylogenetic relationships relationships between between H3K4H3K4 KMTs KMTs from from yeast yeast (S. (S. cerevisiae cerevisiae),), fruit fruit ﬂies flies (D. (D. melanogaster melanogaster) and) and humans humans (H. (H. sapiens sapiens). ).

5. RolesH3K4 of methylation H3K4 Methylation is catalyzed in Regulating by a series Aging of KMTs, in Different using SAM Species as a methyl group donor. In S. cerevisiae (yeast), Set1 is the sole H3K4 KMT. The yeast complex associated 5.1. H3K4 Methylation Contributes to Pathways that Regulate Yeast Aging and Lifespan with Set1 (COMPASS) consists of a catalytic subunit Set1 and the concerted action of seven regulatoryLike subunitsC. elegans (Swd1,, the budding Swd2, Swd3, yeast, Bre2, S. cerevisiae Sdc1, Spp1, is andwidely Shg1), recognized which are as responsible one of the forsimplest generating and most H3K4me1, powerful H3K4me2, organisms and for H3K4me3 aging research. [79]. Drosophila Yet, despite melanogaster the simplicity(fruit of ﬂy)this carries unicellular three eukaryote, Set1 homologs, the mechanisms dSet1, Trithorax underlying (Trx), and yeast-aging Trithorax-related phenotypes (Trr); are dSet1 sur- isprisingly responsible similar for to depositing those seen the in bulkhuman of post-mitotic H3K4me2 and cells H3K4me3 [108]. Aging [82, 83in]. yeast In humans, cells can therebe modeled are six Set1-relatedchronologically proteins and is that assessed form by MLL/COMPASS monitoring cell complexes,survival in stationary including batch two homologscultures after of Set1—hSET1A the diauxic shift. and Thus, hSET1B—and the definition the mixed-lineage of chronological leukemia lifespan (MLL) (CLS) family is the (MLL1,length of 2, 3time and that 4). MLL1yeast survive and MLL2 in the are stat homologsionary phase of D. melanogasterfollowing nutrientTrx, while scarcity. MLL3 In andcontrast MLL4 to are the homologs CLS model of D. of melanogaster aging in post-mitoticTrr [79]. All (or of thedifferentiated) MLL/COMPASS cells, complexesreplicative sharelifespan a four (RLS) subunit represents subcomplex an aging consistingmodel for pr ofoliferating Wdr5, Rbbp5, cells (e.g., Ash2 undifferentiated and Dpy30, which stem arecells) respective and is defined homologs as the of number yeast Swd3, of times Swd1, a mother Bre2 cell and divides Sdc1, and and are produces together a daughter known ascell WRAD before [ 79it enters,84]. The senescence WRAD subcomplexand eventually must dies associate [109]. with different KMTs to form various catalytic complexes, and its presence is essential for full enzymatic activity [85,86]. In C. elegans, the MLL/COMPASS complex contains a WRAD subcomplex associated with one of two KMTs, either the Set1-like SET-2 or the MLL-like SET-16 [85,87,88]. Of note, each complex is endowed with additional proteins that determine H3K4me status and biological functions. In yeast COMPASS, the WD40 protein Swd2, PHD ﬁnger protein Spp1, and Shg1 may be present [79]. In mammalian cells, unique subunits, such as WDR82 (WD repeat Epigenomes 2021, 5, 14 6 of 19

domain 82) in the hSET1A complex, menin in MLL1/2, and PTIP (Pax transactivation domain-interacting protein) in MLL3/4, have roles in regulating H3K4me and recruiting distinct transcription factors for the expression of specific target genes [89–91]. Histone methylation was originally thought to be stable and irreversible [92]. How- ever, in 2004, the discovery of the first H3K4 KDM, human lysine-specific demethylase 1A (KDM1A; also known as LSD1), revealed that H3K4me2 and H3K4me1 can both be removed by KDM1A/LSD1 through an FAD (flavin adenine dinucleotide)-dependent oxidation reaction; thus, histone methylation was shown to be reversible and dynamically regulated [93]. After that pioneering study, JARID1 (jumonji AT-rich interactive domain-1) family proteins (JARID1A/KDM5A, JARID1B/KDM5B, JARID1C/KDM5C and JARID1D/KDM5D) and the JmjC domain-containing protein (nucleolar protein 66 (NO66); also known as MAPJD) were found to serve as H3K4 demethylases in human cells [94,95]. It is noteworthy that unlike KDM1A/LSD1, which catalyzes demethylation specifically on H3K4me1/me2, the KDM5A-D proteins can function as demethylases for all three states of H3K4me [94,96]. Much of the evidence supporting the idea that H3K4me may play a crucial role in aging comes from studies in which the levels of KMTs and KDMs were modulated in C. elegans. In the C. elegans genome, there are three KDM1 genes (amx-1, spr-5, and lsd-1) and one KDM5 gene (rbr-2). The amx-1 gene encodes the sole KDM1B enzyme, while the other two KDM1 genes are KDM1A homologs. The sole KDM5 member, RBR-2, can act as a demethylase for H3K4me3 and H3K4me2, but it is more efficient at removing H3K4me3 [97]. In contrast, the KDM1 members (SPR-5, LSD-1, and AMX-1) are responsible for removing H3K4me1 and H3K4me2 [98–102]. Interestingly, targeting different classes of KDMs (KDM1 versus KDM5) may differentially affect the aging process [103,104]. Despite this context specificity, it is clear that KDM-modulated H3K4 demethylation is functionally relevant during aging, and follow-up studies to delineate the mechanisms will help reconcile any apparent discrepancies [105–107].

5. Roles of H3K4 Methylation in Regulating Aging in Different Species 5.1. H3K4 Methylation Contributes to Pathways That Regulate Yeast Aging and Lifespan Like C. elegans, the budding yeast, S. cerevisiae, is widely recognized as one of the simplest and most powerful organisms for aging research. Yet, despite the simplicity of this unicellular eukaryote, the mechanisms underlying yeast-aging phenotypes are surprisingly similar to those seen in human post-mitotic cells [108]. Aging in yeast cells can be modeled chronologically and is assessed by monitoring cell survival in stationary batch cultures after the diauxic shift. Thus, the definition of chronological lifespan (CLS) is the length of time that yeast survive in the stationary phase following nutrient scarcity. In contrast to the CLS model of aging in post-mitotic (or differentiated) cells, replicative lifespan (RLS) represents an aging model for proliferating cells (e.g., undifferentiated stem cells) and is defined as the number of times a mother cell divides and produces a daughter cell before it enters senescence and eventually dies [109]. In yeast, a hint that H3K4me may play a role in aging first came from the observation that cells with loss of H3K4me, due to deficiencies in any of the three subunits of COMPASS (Set1, Spp1, and Bre2), exhibit a shortened CLS [46]. However, the link between H3K4me and the aging process was still not clear, as Walter at al. further showed that the loss of H3K4me during chronological aging can trigger cell death in yeast, which could explain the shorter lifespan [46]. Recently, the importance of H3K4me3 in regulating dynamic transcriptional changes in response to aging has been demonstrated [59]. A link was made between H3K4me3 and the inducible expression of a subset of genes known to be upregulated with age, highlighting the direct role of H3K4me3 in maintaining the normal expression of many genes across the lifespan. Consistent with this notion, age-associated H3K4me3 dynamics in C. elegans were shown to be highly correlated with changes in RNA expression of genes commonly implicated in aging biology [60]. Epigenomes 2021, 5, 14 7 of 19

5.2. H3K4 Methylation Modulates Aging in Nematodes and Fruit Flies H3K4me deposition has strong implications for aging not only in yeast but also in nematodes and fruit flies. In C. elegans, RNAi knockdown or mutations in genes encoding members of the H3K4 KMT complex (ash-2, set-2 and wdr-5) lead to H3K4me3 deficiency and concomitantly extend lifespan [103]. Moreover, the lifespan extension phenotype caused by ASH-2 knockdown is suppressed by the sole C. elegans KDM5 demethylase, RBR-2, suggesting an epistatic relationship between these two opposed H3K4me modi- fiers [103]. However, the effects of reducing RBR-2 function on lifespan remain unclear. While some studies, including Greer et al., showed that RBR-2-mediated H3K4 demethylation may promote aging [103,104], others have suggested that RBR-2 deficiency, which presumably upregulates levels of H3K4me3, leads to increased lifespan [100,110,111]. These discrepancies might be explained by the effects of some unidentified H3K4 methyltransferases (other than H3K4 KMTs), which could be influenced by RBR-2 to affect a different set of downstream target genes. Nevertheless, reduced function of KMD1A/LSD-1, another H3K4me KDM in C. elegans, has been reported to increase lifespan [104,112]. In D. melanogaster, a deficiency in Lid, the homolog of RBR-2, causes a decrease in the lifespan of male flies, although the same effect on lifespan was not observed in female flies [113]. Intriguingly, effects on lifespan are not always observed when modulating H3K4me regulators in flies; for example, loss-of-function in Trr, a member of another H3K4 KMT complex in D. melanogaster, does not alone affect the lifespan of male flies [114].

5.3. H3K4 Methylation Is Associated with Age-Related Diseases in Mouse Models A study to profile transcriptome, DNA methylome, and histone modifications of young and old murine hematopoietic stem cells (HSCs) revealed an age-dependent increase in the breadth of more than 50% of all H3K4me3 peaks (especially on genes in which H3K4me3 is already broad), which most likely contributes to the dysfunction of HSCs in the older animals [115]. Furthermore, the broadened peaks tend to be associated with genes that determine HSC identity [115], suggesting that the increase in this activating mark on these particular genes may be linked to functional changes in aged HSCs. This argument is also consistent with the findings of another study that showed the broadest H3K4me3 domains control the cell-identity-related genes by increasing their transcriptional consistency [56]. On the other hand, a recent study using a similar integrative characterization of epigenomic and transcriptomic changes during normal human HSC aging demonstrated that aging is associated with significant reductions in H3K27ac (activating mark), H3K4me1 and H3K4me3; furthermore, the sites with decreased H3K4me1 were associated with genes involved in myeloid and erythroid differentiation and function, while those with lost H3K27ac were linked to genes involved in leukocyte activation, apoptotic signaling and histone modifications [116]. More importantly, the molecular pathways targeted by this age-related epigenetic reprogramming were shown to be similarly altered in acute myeloid leukemia (AML), suggesting that such reprogramming with age may predispose individuals to the development of AML [116]. The role of epigenetics in age-related disease was also investigated in an Alzheimer’s disease (AD) mouse model [117]. In the AD mice, H3K4me3 and its catalyzing enzymes are significantly increased in the prefrontal cortex (PFC), a key brain region impaired in AD, and treating AD mice with a specific inhibitor of H3K4 KMTs results in substantial recovery of PFC functions [117]. This study not only revealed a novel role for H3K4me3 in AD pathophysiology, but it also predicts a novel molecular target for AD therapy, providing a potentially valuable resource for further studies on AD and age-related neurodegenera- tive disorders. Recently, Sleiman et al. used multiple genomic methods to measure changes in the transcriptome, DNA methylome and histone modifications in three metabolic tissues (liver, heart and muscle) of adult and aged mice [118]. Among the three tissues, heart and muscle show global increases in chromatin accessibility, and the Gene Ontology (GO) enrichments for genes with both increased H3K27ac (activating mark) and decreased Epigenomes 2021, 5, 14 8 of 19

H3K27me3 (repression mark) imply a role for open chromatin in aging. However, no functional enrichments for changes in H3K4me3 were observed in the three tissues [118]. As for histone modifications, the results indicate that the epigenetic footprint of aging is strikingly tissue specific, with the greatest changes of H3K4me3 observed in muscle [118]. An age-related decline in muscle mass and function is called sarcopenia and considered to be a major risk factor for disease in the elderly [119]. In human aging cohort studies, sarcopenia was suggested to have origins in fetal and early life [120,121], suggesting that epigenetic modifications, such as H3K4 methylation, are likely to underpin muscle memory [122].

5.4. The Relationship between Regulation of H3K4 Methylation and Cell Senescence In Humans Cellular senescence is a state of stable cell cycle arrest that has been implicated in aging, as the accumulation of senescent cells is associated with aging and age-related diseases [123,124]. In human cells, a profound redistribution of H3K4me3 in the genome occurs upon senescence [125]. In their study, Shah et al. compared genome-wide H3K4me3 distributions in primary skin fibroblasts of controls and HGPS (Hutchinson–Gilford proge- ria syndrome) patients, who have a segmental premature aging syndrome associated with accelerated cell senescence. In this comparison, the authors found large-scale chromatin changes, including the acquisition of large contiguous stretches of altered H3K4me in HGPS patients. Gene expression analysis further showed that H3K4me3 is enriched at upregulated genes, and it is depleted at downregulated genes, especially those with functions in cell cycle and proliferation. These results revealed a surprising link between global changes in H3K4me3 distribution and accelerated aging, presumably due to chromatin changes during premature senescence [125]. However, the functional implications of large-scale epigenomic alterations in senescent cells are not yet clear. As broad H3K4me domains are important for the precise regulation of transcriptional activity for key cell identity/function genes [56], it is possible that the broadly spread H3K4me3 deposits observed during senescence/aging could influence the expression of particular gene sets to affect the cellular phenotype. An alternative possibility is that the profound change in H3K4 methylation distribution may contribute to genome reorganization. Deficiency of Cfp1, a conserved subunit of the Set1 complex in mice, causes a shift of H3K4me3 from the promoters of expressed genes to numerous “ectopic sites”; however, there are minimal consequences for transcription. Further analysis revealed that these ectopic peaks are enriched in cohesion- and CTCF-binding sites, which are thought to mediate chromatin looping [126]. Moreover, chromosome folding analysis in budding yeast by a Hi-C-based method, called Micro-C, revealed abundant chromosome interaction domains (CIDs), which are similar to the reported topologically associating domains (TADs) in mammals [127]. Strong boundaries between CIDs occur at promoters of highly transcribed genes, and intriguingly, nucleo- somes at the boundaries exhibit significant enrichments of a variety of histone marks at the 50 ends of genes [128], including high levels of H3K4me3. Together, these results imply a role for H3K4 methylation in chromatin organization. Furthermore, a global genetic analysis of gene pairs in yeast revealed that the deletion of SET1 positively interacts with mutations in subunits of cohesin and condensin [129], which suggests functionally prox- imal relationships between the proteins. Thus, there is good reason to expect a possible functional role for H3K4me in regional and/or global chromatin organization. H3K4me3 also exists alongside the repressive H3K27me3 mark in so-called bivalent chromatin domains, which are usually seen at promoters of key developmental regulators in stem or progenitor cells. In stem cells, the genes marked with bivalent domains are poised to be quickly activated upon the loss of H3K27me3 during differentiation and development. Intriguingly, the bivalent chromatin domain promoters are preferential sites for DNA hypermethylation in some aged human tissues, and the sites are also methylated and silenced in cancers [130,131]. Given the nature of their pro-differentiation functions, bivalent-marked genes tend to have tumor suppressor-like properties, meaning that their methylation and stable silencing can promote proliferation, self-renewal and Epigenomes 2021, 5, 14 9 of 19

malignancy. These studies support the idea that age-associated methylation changes in bivalent chromatin domains might act as one of the multiple “hits” required for the transformation of aged cells.

6. Metabolic Signaling Pathways Involving H3K4 Methylation 6.1. One-Carbon Metabolism The methylation of H3K4, like the methylation of other sites on histones and DNA, requires the metabolite, SAM (universal methyl group donor). SAM is generated by one- carbon metabolism (Figure3), a fundamental metabolic pathway that couples the folate and methionine cycles. The latter cycle is particularly relevant to histone methylation, as it provides a direct link to histone substrates through the generation of SAM. SAM is synthesized from ATP and methionine by the enzymatic action of methionine adenosyltransferase (MAT), also known as SAM synthetase (SAM-S) [132]. Histone methyltransferases (HMTs), such as H3K4 KMTs, transfer a methyl group from SAM to histone substrates, yielding S-adenosylhomocysteine (SAH) and a methylated histone [25,133]. SAH is a potent product inhibitor of SAM-dependent methylation, and it is efﬁciently converted to homocysteine (Hcy) and adenine via S-adenosylhomocysteine hydrolase (SAHH) [134]. The inhibition of SAHH causes abnormal accumulation of SAH, which inhibits the methylation reaction via a feedback mechanism. Cells generally maintain low concentrations of SAH, and the ratio of cellular SAH/SAM is frequently used as an indicator of cellular methylation status. To complete the methionine cycle, Hcy can be remethylated back to methionine Epigenomes 2021, 5, x FOR PEER REVIEWby the donation of a methyl group either from 5-methyltetrahydrafolate (5-meTHF)10 of or 20 from betaine, which is catalyzed by methionine synthase (MS) or betaine-homocysteine S-methyltransferase (BHMT), respectively.

FigureFigure 3. 3.Histone Histone methylation methylation reaction reaction and and one-carbon one-carbon metabolism. metabolism.S -adenosylmethionineS-adenosylmethionine (SAM) (SAM) isis synthesized synthesized from from ATP ATP and and methionine methionine (Met) (Met) by by methionine methionine adenosyltransferase adenosyltransferase (MAT). (MAT). Histone Histone methyltransferasesmethyltransferases (HMTs), (HMTs), such such as as H3K4 H3K4 KMTs, KMTs, utilize utilize SAM SAM as as a a cofactor cofactor to to transfer transfer a methyla methyl groupgroup to to the the histone histone substrate, substrate, yielding yieldingS -adenosylhomocysteineS-adenosylhomocysteine (SAH) (SAH) and and a a methylated methylated histone. histone. InIn the the methionine methionine cycle, cycle, SAHSAH isis converted to to homocysteine homocysteine (Hcy) (Hcy) via via S-adenosylhomocysteineS-adenosylhomocysteine hy- hydrolasedrolase (SAHH), (SAHH), followed followed by the re-methylation ofof HcyHcyback back to to methionine methionine via via either either methionine methionine synthase (MS) utilizing a methyl group from 5-methyltetrahydrafolate (5-meTHF) or by betaine- synthase (MS) utilizing a methyl group from 5-methyltetrahydrafolate (5-meTHF) or by betaine- homocysteine S-methyltransferase (BHMT) utilizing a methyl group from betaine. In the folate cy- homocysteine S-methyltransferase (BHMT) utilizing a methyl group from betaine. In the folate cycle, cle, folic acid is reduced to tetrahydrofolate (THF), which can then accept a one-carbon unit from folicserine acid (Ser) is reduced or glycine to tetrahydrofolate (Gly), producing (THF), 5-meTHF. which Threonine can then accept (Thr) ais one-carbonalso involved unit in from modulating serine (Ser)SAM or concentrations, glycine (Gly), producingas it provides 5-meTHF. both glycine Threonine and acetyl-CoA (Thr) is also required involved for in optimal modulating synthesis SAM of concentrations,SAM. as it provides both glycine and acetyl-CoA required for optimal synthesis of SAM.

Epigenomes 2021, 5, 14 10 of 19

In the folate cycle, folic acid is reduced to tetrahydrofolate (THF), which can then accept a one-carbon unit from either serine or glycine to generate 5-meTHF. As mentioned above, 5-meTHF can supply a methyl group for the generation of methionine via MS, yielding THF. Notably, metabolites of folate, THF and 5-meTHF are precursors of pyrimidines and purines, which are essential components of nucleic acids.

6.2. One-Carbon Metabolism and Its Regulation of H3K4 Methylation The availability of methionine and other components of the methionine cycle, such as SAM or SAH, can directly influence histone methylation, including the deposition of H3K4me. While earlier evidence provided links between the metabolic regulation of SAM and SAH and the epigenetic status of cells [135–139], the most direct evidence connecting one-carbon metabolism with H3K4me3 comes from a study performed by Mentch et al. In their study, the authors specifically show that in cells and mice, SAM levels and the SAM/SAH ratio, which can be quantitatively tuned through the modulation of methionine bioavailability, are sufficient to drive rapid changes in H3K4me3 levels, leading to altered gene transcription [25]. In addition, this metabolic–epigenetic axis can run in reverse through a signal transduction-mediated feedback mechanism. As such, methionine-restriction-induced decreases in H3K4me3 directly contribute to the transcriptional downregulation of a network of genes involved in one-carbon metabolism [25]. This mechanism might serve to maintain physiological homeostasis. Later, a follow-up study by Dai et al. revealed a specific mechanism of how alterations in methionine metabolism might influence H3K4me3 and change gene expression. In that study, the authors concluded that the peak width is the most informative parameter in H3K4me3 dynamics upon changes in nutrient availability and is indeed linked to the functional outcomes [140]. The observation that low methionine has direct impacts on both SAM and H3K4me3 was also made in mammalian cells (immortalized mouse embryonic fibroblasts) and S. pombe [141,142]. Threonine (Thr) is another amino acid that can affect SAM concentrations, as it provides a source of both glycine and acetyl-CoA, which are required for optimal synthesis of SAM. Interestingly, just like the effect of methionine restriction on H3K4me3, either Thr restriction or the depletion of threonine dehydrogenase (a mitochondrial enzyme that hydrolyzes Thr into acetyl-CoA and glycine) in mouse embryonic stem cells (mESCs) could significantly reduce SAM levels and selectively diminish H3K4me2/me3. The disappearance of H3K4me2/me3 was then linked to slowed growth and increased differentiation [138]. As mentioned in the previous section, folate is an essential cofactor in the generation of endogenous methionine. Therefore, several classical studies reported links between folate deficiency and reduced SAM concentrations in different animal and cell models [143–146]. However, this correlation is not always observed. Other more recent studies have shown that a severe folate deficiency may actually increase SAM concentrations [147,148]. These reported increases in SAM level are likely attributable to SAH-mediated inhibition of methyltransferases. The results also support the idea that SAH concentration may be a sensitive biomarker of cellular methylation status [137,143,149]. Interestingly, in S. cerevisiae, the analysis of a folate-auxotrophic (fol3∆) revealed that low folate concentrations cause a decrease in H3K4me3/me3 and affect gene expression. Similarly, the SAM levels in fol3∆ cells do not show significant changes, suggesting a SAM (or even a methionine)- independent regulatory mechanism underlying this metabolic–epigenetic crosstalk. On the other hand, folate has been suggested to play an active and direct role in H3K4me- mediated gene expression. In 2011, the LSD1 H3K4 demethylase was identified as a folate- binding protein, and the binding of folate did not inhibit LSD1 activity [150]. Subsequent studies of the crystal structure of LSD1•CoREST (co-repressor for repressor element 1 silencing transcription factor) complexed with THF (tetrahydrofolate) revealed that the THF molecule is in close proximity to the substrate-binding cavity, occupying the place of the H3K4 side chain. Therefore, the authors concluded that the biological importance of the bound folate is to serve as an acceptor for the byproduct, formaldehyde, thus preventing the Epigenomes 2021, 5, 14 11 of 19

accumulation of this potentially toxic molecule [151]. Furthermore, the interplay between folate, LSD1 and H3K4me was demonstrated in the livers of mice fed with a folate-deﬁcient diet. In the liver, H3K4me is substantially elevated due to decreased activity of LSD1, which results from the lack of available folate to scavenge formaldehyde molecules [152]. In summary, SAM, Thr and folate all have the potential to serve as components of a bio-sensing metabolic mechanism to convey information about metabolic changes to histone modiﬁcations, eventually affecting gene expression to drive cellular responses to the overall metabolic state.

6.3. Methionine and Its Involvement in Aging Methionine restriction (MR) is a widely known dietary manipulation that can induce lifespan extension in many different eukaryotic species, ranging from yeast to nematodes, fruit flies and mice [22,23,153,154]. Aside from increasing longevity, other metabolic bene- fits of MR have also been reported, including decreased inflammation [155,156], reduced oxidative stress [157–159], lower body weights [160,161], and increased insulin sensitiv- ity [162,163]. The mechanisms underlying lifespan extension by MR are complicated and still not fully understood. In terms of cell physiology, the activation of autophagic flux and concomitant vacuole acidification have been suggested as potential mechanisms in yeast, as the deletion of autophagy-related genes or lowering vacuolar acidification ab- rogates MR-mediated CLS extension [153]. In addition, MR-mediated CLS extension at least partially relies on the key signaling protein of the mitochondrial retrograde response (mitochondrial–nuclear communication), as loss-of-function in Rtg3 suppresses the changes in 20% of differentially expressed genes under MR [164]. However, the molecular mechanisms underlying the MR-mediated lifespan extension remain to be elucidated. The epigenetic response to MR has been examined in recent work, as it relates to aging [14]. The ratio of SAM/SAH in cell culture media, which can be directly altered by methionine concentrations in a physiologically relevant range, may affect the methylation state of H3K4 and gene regulation [25]. Moreover, upon MR, the methionine concentrations in human serum are affected enough to change histone methylation [25]. Similarly, MR-induced alterations in DNA methylation and concomitant decreases in SAH were observed only in adult but not young mice fed with low-methionine diets, in an age-dependent effect [165]. Taking these data together, it is tempting to speculate that MR-induced changes in SAM and/or SAH availability might be capable of altering epigenetic profiles that might contribute to lifespan regulation. However, so far, no direct linkage between MR-induced epigenetic changes and aging phenotypes has been made, even though previous studies collectively support the idea that MR causes alterations in epigenetic marks. In addition, given the complexity of the aging process, it is a near certainty that multiple mechanisms are involved in mediating MR effects on lifespan. For example, a decrease in SAM levels upon MR was shown to promote lifespan extension via SAMTOR-dependent inhibition of the mTORC1 (mechanistic target of rapamycin complex 1) signaling pathway [166]. This complexity may impede the interpretation of experimental results, as some mechanisms may be masked or especially important under certain conditions.

7. Conclusions and Perspectives In this review, we summarize current knowledge regarding the role of H3K4me in the aging of eukaryotes. Overall, the molecular mechanisms of how H3K4me contributes to longevity are largely unknown. While alterations in the H3K4me status are not likely to account for many cellular aspects of aging, it is reasonable to expect that H3K4me-mediated alterations in the expression of certain genes are an important determinant of lifespan, as H3K4me has long been strongly associated with transcriptional activation. Indeed, numerous studies have addressed the role of H3K4me in regulating transcription during aging, asking whether the disruption of this process leads to the loss of transcriptional precision that is detrimental to longevity [59,60]. This line of research reﬂects two common themes in Epigenomes 2021, 5, 14 12 of 19

aging studies. First, aging is associated with progressive changes in chromatin marks, and second, age-associated changes in transcription regulatory networks have the potential to impact cellular function, thus contributing to aging phenotypes and diseases [14,167]. H3K4me deposition can be influenced by nutrition and metabolites involved in methionine metabolism. For example, methionine is utilized in the methionine cycle as a methyl donor in the production of SAM. SAM is then used as a cofactor in the methylation of H3K4, and its deficiency was found to specifically reduce H3K4me at the promoters of key genes involved in cell proliferation of CD4+ T helper (Th) cells [168]. Interestingly, MR has long been known to robustly extend lifespan across different species [19]. Based on the nutrition–genome interaction observed in Th cells and the known role of H3K4me in aging, it is tempting to speculate that in the context of aging, H3K4me may act as an interface connecting metabolic signals with the aging process via its function in regulating gene expression. On the other hand, the loss of H3K4me3 only has minor effects on transcription in yeast and mammals [52,54], and H3K4me has been suggested to be a consequence, not a cause of transcription [55]. Thus, it is still debatable whether a role exists for H3K4me in regulating age-associated gene expression. Furthermore, in the study suggesting a mechanistic link between age-dependent H3K4me3 dynamics, gene expression changes, and physiological aberrations in C. elegans somatic cells, the conclusions are drawn from changes in 30% of H3K4me3-enriched regions that largely mark gene bodies [60]. This location is incongruent with the canonical model that gene regulatory function may be attributed to H3K4me3 deposited near the promoter region. Thus, it is clear that unique patterns of H3K4me3 are prone to change during aging, but the functional roles might not be solely limited to gene regulation. H3K4me is also known to be involved in various Epigenomes 2021, 5, x FOR PEER REVIEW 13 of 20 cellular functions, such as DNA replication, replication stress, DNA damage response, the assembly of the mitotic spindle, and apoptosis [42–47]. Importantly, impairments of cellular responses to replication stress and DNA damage have been associated with agingwith aging [169– [169–171],171], suggesting suggesting that that these these mechanisms mechanisms also also can can potentiallypotentially be be influenced influenced by age-dependentby age-dependent H3K4me H3K4me dynamics dynamics (Figure (Figure4). 4). Thus, Thus, future future studies studies to investigateto investigate and and refine therefine role the of role H3K4me of H3K4me dynamics dynamics in longevity in longev areity expected are expected to yield to yi valuableeld valuable insights insights into the natureinto the and nature control and ofcontrol organismal of organismal aging. aging.

FigureFigure 4. PossiblePossible molecular molecular mechanisms mechanisms of aging-associated of aging-associated H3K4 methylation. H3K4 methylation. A simplified A simpliﬁedillus- illustrationtration of H3K4me of H3K4me occupancy occupancy is presented. is presented. Transcription Transcription may be maymodulated be modulated by H3K4me3 by H3K4me3 near pro- near promoters,moters, H3K4me2 H3K4me2 just downstream just downstream of promoters, of promoters, and promoter-distal and promoter-distal H3K4me1. H3K4me1. H3K4me3 H3K4me3 is also is enriched near early-firing origins, and it is involved in faithful DNA replication under both normal also enriched near early-ﬁring origins, and it is involved in faithful DNA replication under both growth conditions and replication stress. As patterns of H3K4me change during aging, the func- normaltional roles growth might conditions not only be and involved replication in gene stress. regulation As patterns but also of in H3K4me other cellular change processes, during aging,such the functionalas replication roles stress might response. not only Th beerefore, involved future in gene mechanistic regulation stud buties also on thein other relationships cellular processes, between such asH3K4me replication and stress aging-related response. processes Therefore, may future provide mechanistic valuable studies insights on the into relationships the underlying between mecha- H3K4me andnisms aging-related of aging. processes may provide valuable insights into the underlying mechanisms of aging.

Funding: This research was funded by Ministry of Science and Technology (Taiwan), grant number MOST109-2320-B-001-017-MY3 and Academia Sinica (Taiwan), grant number AS-108-TP-L07. Conflicts of Interest: The authors declare no conflict of interest.

Reference 1. Partridge, L.; Deelen, J.; Slagboom, P.E. Facing up to the global challenges of ageing. Nat. Cell Biol. 2018, 561, 45–56, doi:10.1038/s41586-018-0457-8. 2. Sen, P.; Shah, P.P.; Nativio, R.; Berger, S.L. Epigenetic Mechanisms of Longevity and Aging. Cell 2016, 166, 822–839, doi:10.1016/j.cell.2016.07.050. 3. López-Otín, C.; Galluzzi, L.; Freije, J.M.; Madeo, F.; Kroemer, G. Metabolic Control of Longevity. Cell 2016, 166, 802–821, doi:10.1016/j.cell.2016.07.031. 4. Fontana, L.; Partridge, L.; Longo, V.D. Extending Healthy Life Span--From Yeast to Humans. Science 2010, 328, 321–326, doi:10.1126/science.1172539. 5. Kubben, N.; Misteli, T. Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat. Rev. Mol. Cell Biol. 2017, 18, 595–609, doi:10.1038/nrm.2017.68. 6. Zhang, W.; Qu, J.; Liu, G.-H.; Belmonte, J.C.I. The ageing epigenome and its rejuvenation. Nat. Rev. Mol. Cell Biol. 2020, 21, 137– 150, doi:10.1038/s41580-019-0204-5. 7. Michalak, E.; Burr, M.; Bannister, A.J.; Dawson, M.A. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat. Rev. Mol. Cell Biol. 2019, 20, 573–589, doi:10.1038/s41580-019-0143-1. 8. Gil, J. Cellular senescence causes ageing. Nat. Rev. Mol. Cell Biol. 2019, 20, 388, doi:10.1038/s41580-019-0128-0. 9. Covarrubias, A.J.; Perrone, R.; Grozio, A.; Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 2021, 22, 119–141, doi:10.1038/s41580-020-00313-x. 10. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The Hallmarks of Aging. Cell 2013, 153, 1194–1217, doi:10.1016/j.cell.2013.05.039.

Epigenomes 2021, 5, 14 13 of 19

Funding: This research was funded by Ministry of Science and Technology (Taiwan), grant number MOST109-2320-B-001-017-MY3 and Academia Sinica (Taiwan), grant number AS-108-TP-L07. Conﬂicts of Interest: The authors declare no conﬂict of interest.

References 1. Partridge, L.; Deelen, J.; Slagboom, P.E. Facing up to the global challenges of ageing. Nat. Cell Biol. 2018, 561, 45–56. [CrossRef] 2. Sen, P.; Shah, P.P.; Nativio, R.; Berger, S.L. Epigenetic Mechanisms of Longevity and Aging. Cell 2016, 166, 822–839. [CrossRef] 3. López-Otín, C.; Galluzzi, L.; Freije, J.M.; Madeo, F.; Kroemer, G. Metabolic Control of Longevity. Cell 2016, 166, 802–821. [CrossRef] 4. Fontana, L.; Partridge, L.; Longo, V.D. Extending Healthy Life Span–From Yeast to Humans. Science 2010, 328, 321–326. [CrossRef] [PubMed] 5. Kubben, N.; Misteli, T. Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat. Rev. Mol. Cell Biol. 2017, 18, 595–609. [CrossRef][PubMed] 6. Zhang, W.; Qu, J.; Liu, G.-H.; Belmonte, J.C.I. The ageing epigenome and its rejuvenation. Nat. Rev. Mol. Cell Biol. 2020, 21, 137–150. [CrossRef] 7. Michalak, E.; Burr, M.; Bannister, A.J.; Dawson, M.A. The roles of DNA, RNA and histone methylation in ageing and cancer. Nat. Rev. Mol. Cell Biol. 2019, 20, 573–589. [CrossRef] 8. Gil, J. Cellular senescence causes ageing. Nat. Rev. Mol. Cell Biol. 2019, 20, 388. [CrossRef][PubMed] 9. Covarrubias, A.J.; Perrone, R.; Grozio, A.; Verdin, E. NAD+ metabolism and its roles in cellular processes during ageing. Nat. Rev. Mol. Cell Biol. 2021, 22, 119–141. [CrossRef] 10. López-Otín, C.; Blasco, M.A.; Partridge, L.; Serrano, M.; Kroemer, G. The Hallmarks of Aging. Cell 2013, 153, 1194–1217. [CrossRef] 11. Benayoun, B.A.; Pollina, E.A.; Brunet, A. Epigenetic regulation of ageing: Linking environmental inputs to genomic stability. Nat. Rev. Mol. Cell Biol. 2015, 16, 593–610. [CrossRef] 12. Gensous, N.; Bacalini, M.G.; Pirazzini, C.; Marasco, E.; Giuliani, C.; Ravaioli, F.; Mengozzi, G.; Bertarelli, C.; Palmas, M.G.; Franceschi, C.; et al. The epigenetic landscape of age-related diseases: The geroscience perspective. Biogerontology 2017, 18, 549–559. [CrossRef][PubMed] 13. Pagiatakis, C.; Musolino, E.; Gornati, R.; Bernardini, G.; Papait, R. Epigenetics of aging and disease: A brief overview. Aging Clin. Exp. Res. 2021, 33, 737–745. [CrossRef][PubMed] 14. Pal, S.; Tyler, J.K. Epigenetics and aging. Sci. Adv. 2016, 2, e1600584. [CrossRef] 15. de Magalhães, J.P.; Curado, J.; Church, G.M. Meta-analysis of age-related gene expression profiles identifies common signa-tures of aging. Bioinformatics 2009, 25, 875–881. [CrossRef] 16. Hu, Z.; Chen, K.; Xia, Z.; Chavez, M.; Pal, S.; Seol, J.-H.; Chen, C.-C.; Li, W.; Tyler, J.K. Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging. Genes Dev. 2014, 28, 396–408. [CrossRef][PubMed] 17. Rangaraju, S.; Solis, G.M.; Thompson, R.C.; Gomez-Amaro, R.L.; Kurian, L.; Encalada, S.E.; Niculescu, A.B.; Salomon, D.R.; Petrascheck, M. Author response: Suppression of transcriptional drift extends C. elegans lifespan by postponing the onset of mortality. Author Response 2015, 4, 08833. [CrossRef] 18. Frenk, S.; Houseley, J. Gene expression hallmarks of cellular ageing. Biogerontology 2018, 19, 547–566. [CrossRef][PubMed] 19. Parkhitko, A.A.; Jouandin, P.; Mohr, S.E.; Perrimon, N. Methionine metabolism and methyltransferases in the regulation of aging and lifespan extension across spe-cies. Aging Cell 2019, 18, e13034. [CrossRef] 20. Peleg, S.; Feller, C.; Ladurner, A.; Imhof, A. The Metabolic Impact on Histone Acetylation and Transcription in Ageing. Trends Biochem. Sci. 2016, 41, 700–711. [CrossRef] 21. Wood, I.C. The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease. Front. Neurosci. 2018, 12, 649. [CrossRef][PubMed] 22. Lee, B.C.; Kaya, A.; Ma, S.; Kim, G.; Gerashchenko, M.; Yim, S.H.; Hu, Z.; Harshman, L.G.; Gladyshev, V.N. Methionine restriction extends lifespan of Drosophila melanogaster under conditions of low amino-acid status. Nat. Commun. 2014, 5, 1–12. [CrossRef] [PubMed] 23. Cabreiro, F.; Au, C.; Leung, K.-Y.; Vergara-Irigaray, N.; Cochemé, H.M.; Noori, T.; Weinkove, D.; Schuster, E.; Greene, N.; Gems, D. Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism. Cell 2013, 153, 228–239. [CrossRef][PubMed] 24. Plummer, J.D.; Johnson, J.E. Extension of Cellular Lifespan by Methionine Restriction Involves Alterations in Central Carbon Metabolism and Is Mitophagy-Dependent. Front. Cell Dev. Biol. 2019, 7, 301. [CrossRef][PubMed] 25. Mentch, S.J.; Mehrmohamadi, M.; Huang, L.; Liu, X.; Gupta, D.; Mattocks, D.; Padilla, P.G.; Ables, G.; Bamman, M.M.; Thalacker- Mercer, A.E. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Me-tabolism. Cell Metab. 2015, 22, 861–873. [CrossRef][PubMed] 26. Shiraki, N.; Shiraki, Y.; Tsuyama, T.; Obata, F.; Miura, M.; Nagae, G.; Aburatani, H.; Kume, K.; Endo, F.; Kume, S. Methionine Metabolism Regulates Maintenance and Differentiation of Human Pluripotent Stem Cells. Cell Metab. 2014, 19, 780–794. [CrossRef] Epigenomes 2021, 5, 14 14 of 19

27. Lu, C.; Ward, P.; Kapoor, G.S.; Rohle, D.; Turcan, S.; Abdel-Wahab, O.; Edwards, C.R.; Khanin, R.; Figueroa, M.E.; Melnick, A.; et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nat. Cell Biol. 2012, 483, 474–478. [CrossRef] 28. Carey, B.W.; Finley, L.W.S.; Cross, J.R.; Allis, C.D.; Thompson, C.B. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nat. Cell Biol. 2015, 518, 413–416. [CrossRef] 29. Pan, M.; Reid, M.A.; Lowman, X.H.; Kulkarni, R.P.; Tran, T.Q.; Liu, X.; Yang, Y.; Hernandez-Davies, J.E.; Rosales, K.K.; Li, H.; et al. Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nat. Cell Biol. 2016, 18, 1090–1101. [CrossRef] 30. Jiang, Y.; Qian, X.; Shen, J.; Wang, Y.; Li, X.; Liu, R.; Xia, Y.; Chen, Q.; Peng, G.; Lin, S.-Y.; et al. Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. Nat. Cell Biol. 2015, 17, 1158–1168. [CrossRef] 31. Arts, R.J.; Novakovic, B.; Ter Horst, R.; Carvalho, A.; Bekkering, S.; Lachmandas, E.; Rodrigues, F.; Silvestre, R.; Cheng, S.C.; Wang, S.Y.; et al. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Im-munity. Cell Metab. 2016, 24, 807–819. [CrossRef] 32. TeSlaa, T.; Chaikovsky, A.C.; Lipchina, I.; Escobar, S.L.; Hochedlinger, K.; Huang, J.; Graeber, T.; Braas, D.; Teitell, M.A. α- Ketoglutarate Accelerates the Initial Differentiation of Primed Human Pluripotent Stem Cells. Cell Metab. 2016, 24, 485–493. [CrossRef] 33. Ye, C.; Sutter, B.M.; Wang, Y.; Kuang, Z.; Tu, B.P. A Metabolic Function for Phospholipid and Histone Methylation. Mol. Cell 2017, 66, 180–193.e8. [CrossRef] 34. Maleszewska, M.; Mawer, J.S.P.; TessarzEmail, P. Histone Modifications in Ageing and Lifespan Regulation. Curr. Mol. Biol. Rep. 2016, 2, 26–35. [CrossRef] 35. Molina-Serrano, D.; Kyriakou, D.; Kirmizis, A. Histone Modifications as an Intersection between Diet and Longevity. Front. Genet. 2019, 10, 192. [CrossRef][PubMed] 36. Allfrey, V.G.; Mirsky, A.E.; Arnon, D.I.; Tsujimoto, H.Y.; McSwain, B.D. Structural Modifications of Histones and their Possible Role in the Regulation of RNA Synthesis. Science 1964, 144, 559. [CrossRef][PubMed] 37. Murray, K. The Occurrence of iε-N-Methyl Lysine in Histones. Biochemistry 1964, 3, 10–15. [CrossRef][PubMed] 38. Honda, B.M.; Dixon, G.H.; Candido, E.P. Sites of in vivo histone methylation in developing trout testis. J. Biol. Chem. 1975, 250, 8681–8685. [CrossRef] 39. Martin, C.; Zhang, Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6, 838–849. [CrossRef] 40. Santos-Rosa, H.; Schneider, R.; Bannister, A.; Sherriff, J.; Bernstein, B.E.; Emre, T.; Schreiber, S.L.; Mellor, J.; Kouzarides, T. Active genes are tri-methylated at K4 of histone H3. Nat. Cell Biol. 2002, 419, 407–411. [CrossRef] 41. Leroy, G.; DiMaggio, P.A.; Chan, E.Y.; Zee, B.; Blanco, M.A.; Bryant, B.; Flaniken, I.Z.; Liu, S.; Kang, Y.; Trojer, P.; et al. A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics Chromatin 2013, 6, 20. [CrossRef] 42. Schibler, A.; Koutelou, E.; Tomida, J.; Wilson-Pham, M.; Wang, L.; Lu, Y.; Cabrera, A.P.; Chosed, R.J.; Li, W.; Li, B.; et al. Histone H3K4 methylation regulates deactivation of the spindle assembly checkpoint through direct binding of Mad2. Genes Dev. 2016, 30, 1187–1197. [CrossRef][PubMed] 43. Beilharz, T.H.; Harrison, P.F.; Miles, D.M.; See, M.M.; Le, U.M.; Kalanon, M.; Curtis, M.J.; Hasan, Q.; Saksouk, J.; Margaritis, T.; et al. Coordination of Cell Cycle Progression and Mitotic Spindle Assembly Involves Histone H3 Lysine 4 Methyla-tion by Set1/COMPASS. Genetics 2017, 205, 185–199. [CrossRef][PubMed] 44. Faucher, D.; Wellinger, R.J. Methylated H3K4, a Transcription-Associated Histone Modification, Is Involved in the DNA Damage Response Pathway. PLoS Genet. 2010, 6, e1001082. [CrossRef][PubMed] 45. Chong, S.Y.; Cutler, S.; Lin, J.-J.; Tsai, C.-H.; Tsai, H.-K.; Biggins, S.; Tsukiyama, T.; Lo, Y.-C.; Kao, C.-F. H3K4 methylation at active genes mitigates transcription-replication conflicts during replication stress. Nat. Commun. 2020, 11, 809. [CrossRef][PubMed] 46. Walter, D.; Matter, A.; Fahrenkrog, B. Loss of histone H3 methylation at lysine 4 triggers apoptosis in Saccharomyces cere-visiae. PLoS Genet. 2014, 10, e1004095. [CrossRef][PubMed] 47. Rizzardi, L.F.; Dorn, E.S.; Strahl, B.D.; Cook, J.G. DNA Replication Origin Function Is Promoted by H3K4 Di-methylation in Saccharomyces cere-visiae. Genetics 2012, 192, 371. [CrossRef] 48. Wang, Y.; Li, X.; Hu, H. H3K4me2 reliably defines transcription factor binding regions in different cells. Genomics 2014, 103, 222–228. [CrossRef] 49. Pekowska, A.; Benoukraf, T.; Ferrier, P.; Spicuglia, S. A unique H3K4me2 profile marks tissue-specific gene regulation. Genome Res. 2010, 20, 1493–1502. [CrossRef] 50. Rada-Iglesias, A.; Bajpai, R.; Swigut, T.; Brugmann, S.A.; Flynn, R.A.; Wysocka, J. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2011, 470, 279–283. [CrossRef] 51. Heintzman, N.D.; Hon, G.C.; Hawkins, R.D.; Kheradpour, P.; Stark, A.; Harp, L.F.; Ye, Z.; Lee, L.K.; Stuart, R.K.; Ching, C.W.; et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nat. Cell Biol. 2009, 459, 108–112. [CrossRef] 52. Margaritis, T.; Oreal, V.; Brabers, N.; Maestroni, L.; Vitaliano-Prunier, A.; Benschop, J.J.; Van Hooff, S.; Van Leenen, D.; Dargemont, C.; Géli, V.; et al. Two Distinct Repressive Mechanisms for Histone 3 Lysine 4 Methylation through Promoting 30-End Antisense Transcription. PLoS Genet. 2012, 8, e1002952. [CrossRef] Epigenomes 2021, 5, 14 15 of 19

53. Clouaire, T.; Webb, S.; Skene, P.; Illingworth, R.; Kerr, A.; Andrews, R.; Lee, J.-H.; Skalnik, D.; Bird, A. Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev. 2012, 26, 1714–1728. [CrossRef] [PubMed] 54. Howe, F.S.; Fischl, H.; Murray, S.C.; Mellor, J. Is H3K4me3 instructive for transcription activation? BioEssays 2017, 39, e201600095-12. [CrossRef][PubMed] 55. Soares, L.M.; He, P.C.; Chun, Y.; Suh, H.; Kim, T.; Buratowski, S. Determinants of Histone H3K4 Methylation Patterns. Mol. Cell 2017, 68, 773–785.e6. [CrossRef] 56. Benayoun, B.A.; Pollina, E.A.; Ucar, D.; Mahmoudi, S.; Karra, K.; Wong, E.D.; Devarajan, K.; Daugherty, A.C.; Kundaje, A.; Mancini, E.; et al. H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency. Cell 2014, 158, 673–688. [CrossRef] 57. Chen, K.; Chen, Z.; Wu, D.; Zhang, L.; Lin, X.; Su, J.; Rodriguez, B.; Xi, Y.; Xia, Z.; Chen, X.; et al. Broad H3K4me3 is associated with increased transcription elongation and enhancer activity at tumor-suppressor genes. Nat. Genet. 2015, 47, 1149–1157. [CrossRef] 58. Dincer, A.; Gavin, D.P.; Xu, K.; Zhang, B.; Dudley, J.T.; Schadt, E.E.; Akbarian, S. Deciphering H3K4me3 broad domains associated with gene-regulatory networks and conserved epigenomic land-scapes in the human brain. Transl. Psychiatry 2015, 5, e679. [CrossRef] 59. Cruz, C.; Della Rosa, M.; Krueger, C.; Gao, Q.; Horkai, D.; King, M.; Field, L.; Houseley, J. Tri-methylation of histone H3 lysine 4 facilitates gene expression in ageing cells. eLife 2018, 7, 7. [CrossRef][PubMed] 60. Pu, M.; Wang, M.; Wang, W.; Velayudhan, S.S.; Lee, S.S. Unique patterns of trimethylation of histone H3 lysine 4 are prone to changes during aging in Caenorhabditis elegans somatic cells. PLoS Genet. 2018, 14, e1007466. [CrossRef][PubMed] 61. Jaiswal, D.; Jezek, M.; Quijote, J.; Lum, J.; Choi, G.; Kulkarni, R.; Park, D.; Green, E.M. Repression of Middle Sporulation Genes in Saccharomyces cerevisiae by the Sum1-Rfm1-Hst1 Complex Is Main-tained by Set1 and H3K4 Methylation. G3 Genes Genomes Genet. 2017, 7, 3971–3982. 62. Karnani, N.; Taylor, C.M.; Malhotra, A.; Dutta, A. Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection. Mol. Biol. Cell 2010, 21, 393–404. [CrossRef] 63. Birney, E.; Stamatoyannopoulos, J.A.; Dutta, A.; Guigo, R.; Gingeras, T.R.; Margulies, E.H.; Weng, Z.; Synder, M.; Dermitzakis, E.T.; Thurman, R.E.; et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447, 799–816. 64. Karnani, N.; Taylor, C.; Malhotra, A.; Dutta, A. Pan-S replication patterns and chromosomal domains defined by genome-tiling arrays of ENCODE genomic areas. Genome Res. 2007, 17, 865–876. [CrossRef][PubMed] 65. Bell, S.P.; Labib, K. Chromosome Duplication in Saccharomyces cerevisiae. Genet. 2016, 203, 1027–1067. [CrossRef][PubMed] 66. MacAlpine, D.M.; Almouzni, G. Chromatin and DNA Replication. Cold Spring Harb. Perspect. Biol. 2013, 5, a010207. [CrossRef] [PubMed] 67. Bleichert, F.; Botchan, M.R.; Berger, J.M. Mechanisms for initiating cellular DNA replication. Science 2017, 355, eaah6317. [CrossRef][PubMed] 68. Labib, K. How do Cdc7 and cyclin-dependent kinases trigger the initiation of chromosome replication in eukaryotic cells? Genes Dev. 2010, 24, 1208–1219. [CrossRef] 69. Natsume, T.; Müller, C.A.; Katou, Y.; Retkute, R.; Gierliński,M.; Araki, H.; Blow, J.J.; Shirahige, K.; Nieduszynski, C.A.; Tanaka, T.U. Kinetochores Coordinate Pericentromeric Cohesion and Early DNA Replication by Cdc7-Dbf4 Kinase Recruit-ment. Mol. Cell 2013, 50, 661–674. [CrossRef] 70. Fang, D.; Lengronne, A.; Shi, D.; Forey, R.; Skrzypczak, M.; Ginalski, K.; Yan, C.; Wang, X.; Cao, Q.; Pasero, P.; et al. Dbf4 recruitment by forkhead transcription factors defines an upstream rate-limiting step in determining origin firing timing. Genes Dev. 2017, 31, 2405–2415. [CrossRef] 71. Knott, S.R.; Peace, J.M.; Ostrow, A.Z.; Gan, Y.; Rex, A.E.; Viggiani, C.J.; Tavaré, S.; Aparicio, O.M. Forkhead transcription factors establish origin timing and long-range clustering in S. cerevisiae. Cell 2012, 148, 99–111. [CrossRef] 72. Rhind, N.R.; Gilbert, D.M. DNA Replication Timing. Cold Spring Harb. Perspect. Biol. 2013, 5, a010132. [CrossRef] 73. Pohl, T.J.; Brewer, B.J.; Raghuraman, M.K. Functional Centromeres Determine the Activation Time of Pericentric Origins of DNA Replication in Saccharomyces cerevisiae. PLoS Genet. 2012, 8, e1002677. [CrossRef][PubMed] 74. Vogelauer, M.; Rubbi, L.; Lucas, I.; Brewer, B.J.; Grunstein, M. Histone acetylation regulates the time of replication origin firing. Molecular Cell 2002, 10, 1223–1233. [CrossRef] 75. Radman-Livaja, M.; Liu, C.L.; Friedman, N.; Schreiber, S.L.; Rando, O.J. Replication and Active Demethylation Represent Partially Overlapping Mechanisms for Erasure of H3K4me3 in Budding Yeast. PLoS Genet. 2010, 6, e1000837. [CrossRef] 76. Rampakakis, E.; Di Paola, D.; Chan, M.K.; Zannis-Hadjopoulos, M. Dynamic changes in chromatin structure through post- translational modifications of histone H3 during rep-lication origin activation. J. Cell. Biochem. 2009, 108, 400–407. [CrossRef] 77. Rondinelli, B.; Schwerer, H.; Antonini, E.; Gaviraghi, M.; Lupi, A.; Frenquelli, M.; Cittaro, D.; Segalla, S.; Lemaitre, J.-M.; Tonon, G. H3K4me3 demethylation by the histone demethylase KDM5C/JARID1C promotes DNA replication origin firing. Nucleic Acids Res. 2015, 43, 2560–2574. [CrossRef] 78. Higgs, M.R.; Sato, K.; Reynolds, J.J.; Begum, S.; Bayley, R.; Goula, A.; Vernet, A.; Paquin, K.L.; Skalnik, D.G.; Kobayashi, W.; et al. Histone Methylation by SETD1A Protects Nascent DNA through the Nucleosome Chaperone Activity of FANCD2. Mol. Cell 2018, 71, 25–41.e6. [CrossRef] Epigenomes 2021, 5, 14 16 of 19

79. Shilatifard, A. The COMPASS Family of Histone H3K4 Methylases: Mechanisms of Regulation in Development and Disease Path-ogenesis. Annu. Rev. Biochem. 2012, 81, 65–95. [CrossRef] 80. Ruthenburg, A.J.; Allis, C.D.; Wysocka, J. Methylation of Lysine 4 on Histone H3: Intricacy of Writing and Reading a Single Epigenetic Mark. Mol. Cell 2007, 25, 15–30. [CrossRef] 81. Hyun, K.; Jeon, J.; Park, K.; Kim, J. Writing, erasing and reading histone lysine methylations. Exp. Mol. Med. 2017, 49, e324. [CrossRef] 82. Mohan, M.; Herz, H.M.; Smith, E.R.; Zhang, Y.; Jackson, J.; Washburn, M.P.; Florens, L.; Eissenberg, J.C.; Shilatifard, A. The COMPASS family of H3K4 methylases in Drosophila. Mol. Cell Biol. 2011, 31, 4310–4318. [CrossRef] 83. Ardehali, M.B.; Mei, A.; Zobeck, K.L.; Caron, M.; Lis, J.T.; Kusch, T. DrosophilaSet1 is the major histone H3 lysine 4 trimethyl- transferase with role in transcription. Embo. J. 2011, 30, 2817–2828. [CrossRef] 84. Dou, Y.; Milne, T.; Ruthenburg, A.J.; Lee, S.; Lee, J.W.; Verdine, G.L.; Allis, C.D.; Roeder, R.G. Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat. Struct. Mol. Biol. 2006, 13, 713–719. [CrossRef] 85. Qu, Q.; Takahashi, Y.-H.; Yang, Y.; Hu, H.; Zhang, Y.; Brunzelle, J.S.; Couture, J.-F.; Shilatifard, A.; Skiniotis, G. Structure and Conformational Dynamics of a COMPASS Histone H3K4 Methyltransferase Complex. Cell 2018, 174, 1117–1126.e12. [CrossRef] 86. Patel, A.; Vought, V.E.; Dharmarajan, V.; Cosgrove, M.S. A novel non-SET domain multi-subunit methyltransferase required for sequential nucleosomal histone H3 methyla-tion by the mixed lineage leukemia protein-1 (MLL1) core complex. J. Biol. Chem. 2011, 286, 3359–3369. [CrossRef] 87. Li, T.; Kelly, W.G. A Role for Set1/MLL-Related Components in Epigenetic Regulation of the Caenorhabditis elegans Germ Line. PLoS Genet. 2011, 7, e1001349. [CrossRef] 88. Xiao, Y.; Bedet, C.; Robert, V.J.P.; Simonet, T.; Dunkelbarger, S.; Rakotomalala, C.; Soete, G.; Korswagen, H.C.; Strome, S.; Palladino, F. Caenorhabditis elegans chromatin-associated proteins SET-2 and ASH-2 are differentially required for histone H3 Lys 4 methylation in embryos and adult germ cells. Proc. Natl. Acad. Sci. USA 2011, 108, 8305–8310. [CrossRef] 89. Lefevre, G.M.; Patel, S.R.; Kim, D.; Tessarollo, L.; Dressler, G.R. Altering a Histone H3K4 Methylation Pathway in Glomerular Podocytes Promotes a Chronic Disease Pheno-type. PLoS Genet. 2010, 6, e1001142. [CrossRef] 90. Lee, J.H.; Skalnik, D.G. Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes. Mol. Cell Biol. 2008, 28, 609–618. [CrossRef] 91. Agarwal, S.K.; Jothi, R. Genome-Wide Characterization of Menin-Dependent H3K4me3 Reveals a Specific Role for Menin in the Regulation of Genes Implicated in MEN1-Like Tumors. PLoS ONE 2012, 7, e37952. [CrossRef] 92. Byvoet, P.; Shepherd, G.; Hardin, J.; Noland, B. The distribution and turnover of labeled methyl groups in histone fractions of cultured mammalian cells. Arch. Biochem. Biophys. 1972, 148, 558–567. [CrossRef] 93. Shi, Y.; Lan, F.; Matson, C.; Mulligan, P.; Whetstine, J.R.; Cole, P.A.; Casero, R.A.; Shi, Y. Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1. Cell 2004, 119, 941–953. [CrossRef] 94. Hojfeldt, J.; Agger, K.; Helin, K. Histone lysine demethylases as targets for anticancer therapy. Nat. Rev. Drug Discov. 2013, 12, 917–930. [CrossRef] 95. Sinha, K.M.; Yasuda, H.; Coombes, M.M.; Dent, S.; De Crombrugghe, B. Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. Embo. J. 2009, 29, 68–79. [CrossRef] 96. Shi, Y. Histone lysine demethylases: Emerging roles in development, physiology and disease. Nat. Rev. Genet. 2007, 8, 829–833. [CrossRef] 97. Christensen, J.; Agger, K.; Cloos, P.; Pasini, D.; Rose, S.; Sennels, L.; Rappsilber, J.; Hansen, K.H.; Salcini, A.E.; Helin, K. RBP2 Belongs to a Family of Demethylases, Specific for Tri-and Dimethylated Lysine 4 on Histone 3. Cell 2007, 128, 1063–1076. [CrossRef][PubMed] 98. Nottke, A.C.; Beese-Sims, S.E.; Pantalena, L.F.; Reinke, V.; Shi, Y.; Colaiácovo, M.P. SPR-5 is a histone H3K4 demethylase with a role in meiotic double-strand break repair. Proc. Natl. Acad. Sci. USA 2011, 108, 12805–12810. [CrossRef] 99. Greer, E.L.; Becker, B.; Latza, C.; Antebi, A.; Shi, Y. Mutation of C. elegans demethylase spr-5 extends transgenerational longevity. Cell Res. 2015, 26, 229–238. [CrossRef] 100. Alvares, S.M.; Mayberry, G.A.; Joyner, E.Y.; Lakowski, B.; Ahmed, S. H3K4 demethylase activities repress proliferative and postmitotic aging. Aging Cell 2013, 13, 245–253. [CrossRef] 101. Wang, S.; Meyer, D.H.; Schumacher, B. H3K4me2 regulates the recovery of protein biosynthesis and homeostasis following DNA damage. Nat. Struct. Mol. Biol. 2020, 27, 1165–1177. [CrossRef][PubMed] 102. Katz, D.J.; Edwards, T.M.; Reinke, V.; Kelly, W.G. A C. elegans LSD1 Demethylase Contributes to Germline Immortality by Reprogramming Epigenetic Memory. Cell 2009, 137, 308–320. [CrossRef][PubMed] 103. Greer, E.; Maures, T.J.; Hauswirth, A.G.; Green, E.M.; Leeman, D.S.; Maro, G.S.; Han, S.; Banko, M.R.; Gozani, O.; Brunet, A. Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans. Nat. Cell Biol. 2010, 466, 383–387. [CrossRef] 104. Maures, T.J.; Greer, E.; Hauswirth, A.G.; Brunet, A. The H3K27 demethylase UTX-1 regulates C. elegans lifespan in a germline- independent, insulin-dependent manner. Aging Cell 2011, 10, 980–990. [CrossRef] 105. Kidder, B.L.; Hu, G.; Zhao, K. KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation. Genome Biol. 2014, 15, R32. [CrossRef] Epigenomes 2021, 5, 14 17 of 19

106. Outchkourov, N.S.; Muiño, J.M.; Kaufmann, K.; van IJcken, W.F.; Koerkamp, M.J.; van Leenen, D.; de Graaf, P.; Holstege, F.C.; Grosveld, F.G.; Timmers, H.M. Balancing of Histone H3K4 Methylation States by the Kdm5c/SMCX Histone Demethylase Mod-ulates Promoter and Enhancer Function. Cell Rep. 2013, 3, 1071–1079. [CrossRef][PubMed] 107. Lussi, Y.; Mariani, L.; Friis, C.; Peltonen, J.; Myers, T.R.; Krag, C.; Wong, G.; Salcini, A.E. Impaired removal of H3K4 methylation affects cell fate determination and gene transcription. Development 2016, 143, 3751–3762. [CrossRef] 108. Longo, V.D.; Fabrizio, P. Chronological Aging in Saccharomyces cerevisiae. Prokaryotic Cytoskelet. 2011, 57, 101–121. [CrossRef] 109. Sinclair, D. Studying the replicative life span of yeast cells. Breast Cancer 2013, 1048, 49–63. [CrossRef] 110. Lee, S.S.; Kennedy, S.; Tolonen, A.C.; Ruvkun, G. DAF-16 Target Genes That Control, C. elegans Life-Span and Metabolism. Science 2003, 300, 644–647. [CrossRef] 111. Ni, Z.; Ebata, A.; Alipanahiramandi, E.; Lee, S.S. Two SET domain containing genes link epigenetic changes and aging in Caenorhabditis elegans. Aging Cell 2011, 11, 315–325. [CrossRef][PubMed] 112. McColl, G.; Killilea, D.W.; Hubbard, A.E.; Vantipalli, M.C.; Melov, S.; Lithgow, G.J. Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans. J. Biol. Chem. 2008, 283, 350–357. [CrossRef] 113. Li, L.; Greer, C.; Eisenman, R.N.; Secombe, J. Essential Functions of the Histone Demethylase Lid. PLoS Genet. 2010, 6, e1001221. [CrossRef][PubMed] 114. Siebold, A.P.; Banerjee, R.; Tie, F.; Kiss, D.; Moskowitz, J.; Harte, P.J. Polycomb Repressive Complex 2 and Trithorax modulate Drosophila longevity and stress resistance. Proc. Natl. Acad. Sci. USA 2010, 107, 169–174. [CrossRef][PubMed] 115. Sun, D.; Luo, M.; Jeong, M.; Rodriguez, B.; Xia, Z.; Hannah, R.; Wang, H.; Le, T.; Faull, K.F.; Chen, R.; et al. Epigenomic Profiling of Young and Aged HSCs Reveals Concerted Changes during Aging that Reinforce Self-Renewal. Cell Stem Cell 2014, 14, 673–688. [CrossRef][PubMed] 116. Adelman, E.R.; Huang, H.-T.; Roisman, A.; Olsson, A.; Colaprico, A.; Qin, T.; Lindsley, R.C.; Bejar, R.; Salomonis, N.; Grimes, H.L.; et al. Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia. Cancer Discov. 2019, 9, 1080–1101. [CrossRef] 117. Cao, Q.; Wang, W.; Williams, J.B.; Yang, F.; Wang, Z.-J.; Yan, Z. Targeting histone K4 trimethylation for treatment of cognitive and synaptic deficits in mouse models of Alzheimer’s disease. Sci. Adv. 2020, 6, eabc8096. [CrossRef][PubMed] 118. Sleiman, M.B.; Jha, P.; Houtkooper, R.; Williams, R.W.; Wang, X.; Auwerx, J. The Gene-Regulatory Footprint of Aging Highlights Conserved Central Regulators. Cell Rep. 2020, 32, 108203. [CrossRef] 119. Shafiee, G.; Keshtkar, A.; Soltani, A.; Ahadi, Z.; Larijani, B.; Heshmat, R. Prevalence of sarcopenia in the world: A systematic review and meta- analysis of general population studies. J. Diabetes Metab. Disord. 2017, 16, 1–10. [CrossRef] 120. Sayer, A.A.; Cooper, C. Fetal programming of body composition and musculoskeletal development. Early Hum. Dev. 2005, 81, 735–744. [CrossRef][PubMed] 121. Patel, H.P.; Al-Shanti, N.; Davies, L.C.; Barton, S.J.; Grounds, M.D.; Tellam, R.L.; Stewart, C.E.; Cooper, C.; Sayer, A.A. Lean mass, muscle strength and gene expression in community dwelling older men: Findings from the Hertford-shire Sarcopenia Study (HSS). Calcif. Tissue Int. 2014, 95, 308–316. [CrossRef] 122. Sharples, A.P.; Stewart, C.E.; Seaborne, R.A. Does skeletal muscle have an ‘epi’-memory? The role of epigenetics in nutritional programming, metabolic disease, aging and exercise. Aging Cell 2016, 15, 603–616. [CrossRef] 123. van Deursen, J.M. The role of senescent cells in ageing. Nature 2014, 509, 439–446. [CrossRef] 124. Childs, B.G.; Durik, M.; Baker, D.J.; Van Deursen, J.M. Cellular senescence in aging and age-related disease: From mechanisms to therapy. Nat. Med. 2015, 21, 1424–1435. [CrossRef] 125. Shah, P.P.; Donahue, G.; Otte, G.L.; Capell, B.; Nelson, D.M.; Cao, K.; Aggarwala, V.; Cruickshanks, H.A.; Rai, T.S.; McBryan, T.; et al. Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev. 2013, 27, 1787–1799. [CrossRef] 126. Ong, C.-T.; Corces, V.G. Enhancer function: New insights into the regulation of tissue-specific gene expression. Nat. Rev. Genet. 2011, 12, 283–293. [CrossRef] 127. Hsieh, T.-H.S.; Weiner, A.; Lajoie, B.; Dekker, J.; Friedman, N.; Rando, O.J. Mapping Nucleosome Resolution Chromosome Folding in Yeast by Micro-C. Cell 2015, 162, 108–119. [CrossRef] 128. Weiner, A.; Hsieh, T.-H.S.; Appleboim, A.; Chen, H.V.; Rahat, A.; Amit, I.; Rando, O.J.; Friedman, N. High-Resolution Chromatin Dynamics during a Yeast Stress Response. Mol. Cell 2015, 58, 371–386. [CrossRef][PubMed] 129. Costanzo, M.; VanderSluis, B.; Koch, E.N.; Baryshnikova, A.; Pons, C.; Tan, G.; Wang, W.; Usaj, M.M.; Hanchard, J.; Lee, S.D.; et al. A global genetic interaction network maps a wiring diagram of cellular function. Science 2016, 353, aaf1420. [CrossRef][PubMed] 130. Rakyan, V.K.; Down, T.A.; Maslau, S.; Andrew, T.; Yang, T.-P.; Beyan, H.; Whittaker, P.; McCann, O.T.; Finer, S.; Valdes, A.; et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010, 20, 434–439. [CrossRef][PubMed] 131. Teschendorff, A.E.; Menon, U.; Gentry-Maharaj, A.; Ramus, S.J.; Weisenberger, D.J.; Shen, H.; Campan, M.; Noushmehr, H.; Bell, C.; Maxwell, A.P.; et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res. 2010, 20, 440–446. [CrossRef][PubMed] 132. Cantoni, G. S-adenosylmethionine. A new intermediate formed enzymatically from l-methionine and adenosinetriphosphate. J. Biol. Chem. 1953, 204, 403–416. [CrossRef] Epigenomes 2021, 5, 14 18 of 19

133. Teperino, R.; Schoonjans, K.; Auwerx, J. Histone Methyl Transferases and Demethylases; Can They Link Metabolism and Transcription? Cell Metab. 2010, 12, 321–327. [CrossRef][PubMed] 134. Tehlivets, O.; Malanovic, N.; Visram, M.; Pavkov-Keller, T.; Keller, W. S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system. Biochim. Biophys. Acta Mol. Basis Dis. 2013, 1832, 204–215. [CrossRef][PubMed] 135. Kraus, D.; Yang, Q.; Kong, D.; Banks, A.S.; Zhang, L.; Rodgers, J.T.; Pirinen, E.; Pulinilkunnil, T.C.; Gong, F.; Wang, Y.-C.; et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nat. Cell Biol. 2014, 508, 258–262. [CrossRef] [PubMed] 136. Ulanovskaya, O.A.; Zuhl, A.M.; Cravatt, B.F. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat. Chem. Biol. 2013, 9, 300–306. [CrossRef][PubMed] 137. Caudill, M.A.; Wang, J.C.; Melnyk, S.; Pogribny, I.P.; Jernigan, S.; Collins, M.D.; Santos-Guzman, J.; Swendseid, M.E.; Cogger, E.A.; James, S.J.; et al. Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of me-thyl-deficient cystathionine beta-synthase heterozygous mice. J. Nutr. 2001, 131, 2811–2818. [CrossRef] 138. Shyh-Chang, N.; Locasale, J.W.; Lyssiotis, C.; Zheng, Y.; Teo, R.Y.; Ratanasirintrawoot, S.; Zhang, J.; Onder, T.; Unternaehrer, J.J.; Zhu, H.; et al. Influence of Threonine Metabolism on S-Adenosylmethionine and Histone Methylation. Science 2013, 339, 222–226. [CrossRef][PubMed] 139. Sadhu, M.; Guan, Q.; Li, F.; Sales-Lee, J.; Iavarone, A.T.; Hammond, M.C.; Cande, W.Z.; Rine, J. Nutritional Control of Epigenetic Processes in Yeast and Human Cells. Genetics 2013, 195, 831–844. [CrossRef] 140. Dai, Z.; Mentch, S.J.; Gao, X.; Nichenametla, S.N.; Locasale, J.W. Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat. Commun. 2018, 9, 1–12. [CrossRef] 141. Kera, Y.; Katoh, Y.; Ohta, M.; Matsumoto, M.; Takano-Yamamoto, T.; Igarashi, K. Methionine Adenosyltransferase II-dependent Histone H3K9 Methylation at the COX-2 Gene Locus. J. Biol. Chem. 2013, 288, 13592–13601. [CrossRef] 142. Hayashi, T.; Teruya, T.; Chaleckis, R.; Morigasaki, S.; Yanagida, M. S-Adenosylmethionine Synthetase Is Required for Cell Growth, Maintenance of G0 Phase, and Termination of Quiescence in Fission Yeast. iScience 2018, 5, 38–51. [CrossRef] 143. Kim, Y.-I.; Miller, J.W.; Da Costa, K.-A.; Nadeau, M.; Smith, D.; Selhub, J.; Zeisel, S.H.; Mason, J.B. Severe Folate Deficiency Causes Secondary Depletion of Choline and Phosphocholine in Rat Liver. J. Nutr. 1994, 124, 2197–2203. [CrossRef] 144. Miller, J.W.; Nadeau, M.R.; Smith, J.; Smith, D.; Selhub, J. Folate-deficiency-induced homocysteinaemia in rats: Disruption of S-adenosylmethionine’s co-ordinate regulation of homocysteine metabolism. Biochem. J. 1994, 298, 415–419. [CrossRef][PubMed] 145. Balaghi, M.; Horne, D.W.; Wagner, C. Hepatic one-carbon metabolism in early folate deficiency in rats. Biochem. J. 1993, 291, 145–149. [CrossRef][PubMed] 146. Kim, Y.I.; Pogribny, I.P.; Basnakian, A.G.; Miller, J.W.; Selhub, J.; James, S.J.; Mason, J.B. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am. J. Clin. Nutr. 1997, 65, 46–52. [CrossRef] [PubMed] 147. Stempak, J.M.; Sohn, K.-J.; Chiang, E.-P.; Shane, B.; Kim, Y.-I. Cell and stage of transformation-specific effects of folate deficiency on methionine cycle intermediates and DNA methylation in an in vitro model. Carcinogenesis 2005, 26, 981–990. [CrossRef] 148. Alonso-Aperte, E.; González, M.P.; Póo-Prieto, R.; Varela-Moreiras, G. Folate status and S-adenosylmethionine/S- adenosylhomocysteine ratio in colorectal adenocarcinoma in humans. Eur. J. Clin. Nutr. 2007, 62, 295–298. [CrossRef] [PubMed] 149. Castro, R.; Rivera, I.; Struys, E.A.; Jansen, E.E.; Ravasco, P.; Camilo, M.E.; Blom, H.J.; Jakobs, C.; Tavares de Almeida, I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular dis-ease. Clin. Chem. 2003, 49, 1292–1296. [CrossRef] 150. Luka, Z.; Moss, F.; Loukachevitch, L.V.; Bornhop, D.J.; Wagner, C. Histone Demethylase LSD1 Is a Folate-Binding Protein. Biochemistry 2011, 50, 4750–4756. [CrossRef][PubMed] 151. Luka, Z.; Pakhomova, S.; Loukachevitch, L.V.; Calcutt, M.W.; Newcomer, M.E.; Wagner, C. Crystal structure of the histone lysine specific demethylase LSD1 complexed with tetrahydrofolate. Protein Sci. 2014, 23, 993–998. [CrossRef][PubMed] 152. Garcia, B.A.; Luka, Z.; Loukachevitch, L.V.; Bhanu, N.V.; Wagner, C. Folate deficiency affects histone methylation. Med Hypotheses 2016, 88, 63–67. [CrossRef][PubMed] 153. Ruckenstuhl, C.; Netzberger, C.; Entfellner, I.; Carmona-Gutierrez, D.; Kickenweiz, T.; Stekovic, S.; Gleixner, C.; Schmid, C.; Klug, L.; Sorgo, A.G.; et al. Lifespan Extension by Methionine Restriction Requires Autophagy-Dependent Vacuolar Acidification. PLoS Genet. 2014, 10, e1004347. [CrossRef][PubMed] 154. Miller, R.A.; Buehner, G.; Chang, Y.; Harper, J.M.; Sigler, R.; Smith-Wheelock, M. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 2005, 4, 119–125. [CrossRef] 155. Bárcena, C.; Quiros, P.M.; Durand, S.; Mayoral, P.; Rodríguez, F.; Caravia, X.M.; Mariño, G.; Garabaya, C.; Fernández-García, M.T.; Kroemer, G.; et al. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism. Cell Rep. 2018, 24, 2392–2403. [CrossRef] 156. Sharma, S.; Dixon, T.; Jung, S.; Graff, E.C.; Forney, L.A.; Gettys, T.W.; Wanders, D. Dietary Methionine Restriction Reduces Inflammation Independent of FGF21 Action. Obesity 2019, 27, 1305–1313. [CrossRef] 157. Maddineni, S.; Nichenametla, S.; Sinha, R.; Wilson, R.P.; Richie, J.P. Methionine restriction affects oxidative stress and glutathione- related redox pathways in the rat. Exp. Biol. Med. 2013, 238, 392–399. [CrossRef] Epigenomes 2021, 5, 14 19 of 19

158. Ying, Y.; Yun, J.; Guoyao, W.; Kaiji, S.; Zhaolai, D.; Zhenlong, W. Dietary l-methionine restriction decreases oxidative stress in porcine liver mitochondria. Exp. Gerontol. 2015, 65, 35–41. [CrossRef] 159. Yang, Y.; Wang, Y.; Sun, J.; Zhang, J.; Guo, H.; Shi, Y.-H.; Cheng, X.; Tang, X.; Le, G. Dietary methionine restriction reduces hepatic steatosis and oxidative stress in high-fat-fed mice by promoting H2S production. Food Funct. 2018, 10, 61–77. [CrossRef] 160. Orgeron, M.L.; Stone, K.P.; Wanders, D.; Cortez, C.C.; Van, N.T.; Gettys, T.W. The Impact of Dietary Methionine Restriction on Biomarkers of Metabolic Health. Prog. Mol. Biol. Transl. Sci. 2014, 121, 351–376. [CrossRef] 161. Plaisance, E.P.; Greenway, F.L.; Boudreau, A.; Hill, K.L.; Johnson, W.; Krajcik, R.A.; Perrone, C.E.; Orentreich, N.; Cefalu, W.T.; Gettys, T.W. Dietary Methionine Restriction Increases Fat Oxidation in Obese Adults with Metabolic Syndrome. J. Clin. Endocrinol. Metab. 2011, 96, E836–E840. [CrossRef] 162. Wanders, D.; Forney, L.A.; Stone, K.P.; Burk, D.H.; Pierse, A.; Gettys, T.W. FGF21 Mediates the Thermogenic and Insulin- Sensitizing Effects of Dietary Methionine Restriction but Not Its Effects on Hepatic Lipid Metabolism. Diabetes 2017, 66, 858–867. [CrossRef] 163. Ables, G.P.; Perrone, C.E.; Orentreich, D.; Orentreich, N. Methionine-Restricted C57BL/6J Mice Are Resistant to Diet-Induced Obesity and Insulin Resistance but Have Low Bone Density. PLoS ONE 2012, 7, e51357. [CrossRef][PubMed] 164. Johnson, J.E.; Johnson, F.B. Methionine Restriction Activates the Retrograde Response and Confers Both Stress Tolerance and Lifespan Extension to Yeast, Mouse and Human Cells. PLoS ONE 2014, 9, e97729. [CrossRef] 165. Mattocks, D.A.; Mentch, S.J.; Shneyder, J.; Ables, G.P.; Sun, D.; Richie, J.P.; Locasale, J.W.; Nichenametla, S.N. Short term methionine restriction increases hepatic global DNA methylation in adult but not young male C57BL/6J mice. Exp. Gerontol. 2017, 88, 1–8. [CrossRef][PubMed] 166. Gu, X.; Orozco, J.M.; Saxton, R.A.; Condon, K.J.; Liu, G.Y.; Krawczyk, P.A.; Scaria, S.M.; Harper, J.W.; Gygi, S.P.; Sabatini, D.M. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 2017, 358, 813–818. [CrossRef][PubMed] 167. Booth, L.N.; Brunet, A. The Aging Epigenome. Mol. Cell 2016, 62, 728–744. [CrossRef] 168. Roy, D.G.; Chen, J.; Mamane, V.; Ma, E.H.; Muhire, B.M.; Sheldon, R.D.; Shorstova, T.; Koning, R.; Johnson, R.M.; Esaulova, E.; et al. Methionine Metabolism Shapes T Helper Cell Responses through Regulation of Epigenetic Reprogramming. Cell Metab. 2020, 31, 250–266.e9. [CrossRef] 169. Ioannidou, A.; Goulielmaki, E.; Garinis, G.A. DNA Damage: From Chronic Inﬂammation to Age-Related Deterioration. Front. Genet. 2016, 7, 187. [CrossRef] 170. Yousefzadeh, M.; Henpita, C.; Vyas, R.; Soto-Palma, C.; Robbins, P.; Niedernhofer, L. DNA damage—How and why we age? eLife 2021, 10, e62852. [CrossRef] 171. Burhans, W.C.; Weinberger, M. DNA replication stress, genome instability and aging. Nucleic Acids Res. 2007, 35, 7545–7556. [CrossRef][PubMed]